Physician profile
Jianping Zhou
NPI 1881636744
$4,131.22
in general payments reported to CMS, 2019-2025
23 companies · $1,199 in 2025
The $1,199 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $439 · 2022: $293 · 2023: $992 · 2024: $1,208 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,385 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,385.40 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,131.13 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $359.71 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $326.03 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $320.36 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Dexcom, INC. | $237.28 | 2023-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Glaxosmithkline, LLC. | $223.81 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $223.36 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.51 | 2023-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $177.40 | 2021-2025 | |
| Exact Sciences Corporation | $142.55 | 2023-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $137.45 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $110.73 | 2023 | Verquvo |
| Astellas Pharma US INC | $99.32 | 2023-2025 | Veozah |
| Axsome Therapeutics, INC. | $96.15 | 2025 | Auvelity |
| Cequr Corporation | $80.77 | 2024 | Cequr Simplicity |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $56.41 | 2023-2025 | Evenity, Prolia |
| Takeda Pharmaceuticals U.S.A., INC. | $51.50 | 2022 | |
| Janssen Pharmaceuticals, INC | $49.86 | 2023-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.12 | 2024-2025 | Xifaxan |
| Neuronetics, INC. | $26.39 | 2023 | Neurostar Tms Therapy System |
| Abbott Laboratories | $24.55 | 2023 | Freestyle Libre 3 |
| Medtronic, INC. | $16.76 | 2024 | Closurefast |
| Life Molecular Imaging LTD | $16.07 | 2024 | Neuraceq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jianping Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.